IO Biotech, Inc.
IOBTQ Healthcare Biotechnology
In the quarter to September 2025, EPS grew 63.9% and free cash flow grew 11.2%, each against the same quarter a year earlier.
Follow IOBTQ
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | |
|---|---|---|---|---|---|---|---|
Net Income |
0.00 | (10.74) | (12.04) | (67.88) | (71.46) | (86.08) | (95.49) |
Depreciation & Amortization |
— | — | — | 0.00 | 0.10 | 0.22 | 0.25 |
Non Cash Items (Other) |
— | — | 1.94 | 28.01 | 7.43 | 8.27 | 10.71 |
Accounts Payable Change |
— | — | (0.47) | 3.41 | 0.08 | (0.13) | 0.78 |
Change in payables and accrued liability |
— | 0.10 | 1.30 | 3.93 | (0.28) | 5.03 | 2.92 |
Change in other assets and liabilities |
— | 0.08 | (0.67) | (8.11) | 4.40 | 0.96 | (1.53) |
Other operating activities |
0.00 | — | — | — | — | — | — |
Operating Cash Flow |
— | (8.89) | (9.96) | (40.65) | (59.73) | (71.74) | (82.35) |
Capital expenditures |
— | — | — | (0.15) | (0.69) | (0.32) | (0.04) |
Investing cash flow |
— | — | — | (0.15) | (0.69) | (0.32) | (0.04) |
Repayment/Issuance of Debt (Net) |
— | 9.01 | — | — | — | — | — |
Equity Repurchase (Common, Net) |
— | — | — | 115.12 | — | 75.06 | — |
Equity Repurchase (Preffered, Net) |
— | — | 5.12 | 149.94 | — | — | — |
Other financial activities |
— | 0.96 | (0.01) | (12.10) | 6.91 | (3.20) | — |
Financing cash flow |
— | 9.01 | 5.10 | 252.95 | (0.14) | 71.86 | — |
Exchange Rate Adjustment |
— | — | 0.41 | (3.76) | (8.52) | 0.80 | (0.77) |
Change in Cash |
— | (0.12) | (4.44) | 208.39 | (68.94) | 0.60 | (83.16) |
Beginning Cash |
— | — | 7.85 | 3.41 | 211.80 | 142.86 | 143.46 |
Ending Cash |
— | — | 3.41 | 211.80 | 142.86 | 143.46 | 60.30 |
Stock Based Compensation |
— | — | 0.06 | 1.79 | 7.04 | 8.06 | 6.53 |
Dividends Paid (Common) |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
— | — | 0.15 | (0.78) | 4.19 | 5.86 | 2.18 |
Issuance/Purchase of Shares |
— | — | 5.12 | 265.06 | — | 75.06 | — |
| Other line items | |||||||
Revenue per Employee |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |